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Introduction
Restless legs syndrome (RLS) of a severity requiring medi-
cal attention has a prevalence of 2–3% in Caucasian popu-
lations. This significant cause of neurological morbidity is 
defined by an insistent urge to move the legs, and is often 
accompanied by uncomfortable and unpleasant sensations 
deep in the legs themselves. Symptoms typically begin or 
worsen at rest, especially in the evening and night, and are 
often relieved by activities such as rubbing, stretching, or 
walking. There is a family history of RLS in approximately 
50% of cases, suggesting genetic risk factors, and significant 
associations have been shown with low serum ferritin, urae-
mia, and pregnancy. In addition, individuals with various 
chronic medical conditions such as cardiovascular disease, 
hypertension, multiple sclerosis, Parkinson’s disease, spinal 
cord disease, and neuropathy have been shown to have an 
increased risk of RLS although proving cause-and-effect is 
difficult. People with RLS have impaired sleep, often associ-
ated with periodic limb movements, and increased risk of 
depression and anxiety, all of which combine to reduce qual-
ity of life. Treatment of RLS involves lifestyle changes, such 
as increased exercise, and management of chronic comor-
bidities. Reversible causes such as low serum ferritin should 
be corrected. Effective medications include dopamine ago-
nists (pramipexole or ropinirole), α2δ agonists (gabapentin 
or pregabalin), or opioids. RLS symptoms can paradoxically 
worsen with extended use of dopamine agonists (‘augmenta-
tion’) leading to a difficult clinical situation where dopamine 
agonist withdrawal is required, often with opioid cover.
This month’s journal club examines three papers looking 
at the causes and consequences of RLS. The first is a meta-
analysis of genome-wide association studies that highlight 
genetic risk factors for RLS. The second and third papers 
demonstrate associations between RLS and suicide or self-
harm and resistant hypertension, respectively, and highlight 
some of the significant morbidities linked to RLS.
Identification of novel risk loci for restless 
legs syndrome in genome‑wide association 
studies in individuals of European ancestry: 
a meta‑analysis
Family studies have estimated the heritability of RLS as 
50–60%, suggesting that there is a strong genetic component 
to disease risk. This risk is polygenic in nature with multi-
ple loci contributing small amounts to the overall RLS risk 
of an individual. This paper combined three large genome-
wide association study (GWAS) data sets of RLS cases and 
controls into a meta-analysis to identify novel risk loci. The 
three data sets all comprised individuals of European ances-
try, but were recruited in different ways. One was from the 
EU-RLS-GENE consortium (Europe, Canada, USA) where 
RLS status was determined by a Neurologist in line with 
accepted international criteria (6228 cases, 10,992 controls), 
the second from the INTERVAL study of blood donors in the 
UK where a validated RLS questionnaire was used to make 
diagnoses (3065 cases, 24,923 controls), and the third from 
the commercial genomics company 23andMe where RLS 
status was determined by the single self-reported response 
to the question “Have you ever been diagnosed with restless 
legs syndrome?” (36,603 cases, 346,723 controls).
Meta-analysis of GWAS summary statistics from a 
discovery data set comprising the EU-RLS-GENE and 
INTERVAL participants and approximately one-sixth of 
the 23andMe individuals found 20 independent signals that 
were significantly associated with RLS. These mapped to 19 
independent genomic loci, 13 of which were novel, and were 
all recapitulated in the replication data set that consisted 
of the remaining 23andMe individuals. Pathway analyses 
found that GWAS signals were significantly more likely 
to be found in genes associated with neurodevelopment, 
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locomotor behaviour, and DNA maintenance and repair. The 
most significant single-nucleotide polymorphism (SNP) was 
found in MEIS1, a gene involved in controlling HOX gene 
expression and specifying neuronal cell type. This SNP has 
a minor allele frequency of 7% and confers a near doubling 
of risk of RLS in an individual carrying it [odds ratio = 1.92 
(1.85–1.99; 95% confidence interval)].
Comment. This large meta-analysis confirmed that RLS is 
a polygenic disorder with multiple relatively common SNPs 
each conferring small amounts of risk. It identified novel 
risk loci and biological pathways for further investigation. 
Of note, only 19.6% of RLS heritability was explained by 
all the SNPs in this meta-analysis, suggesting that there are 
more risk loci to be discovered. This study shows how dif-
ferent data sets, with very different methods for determining 
disease-status, can be effectively combined if the numbers 
are large enough. Data from genomics companies such as 
23andMe can be useful in genetic risk studies even if pheno-
typic information is limited and self-reported. The novel risk 
loci identified in this study will underpin efforts to under-
stand better the pathophysiology of RLS.
Schormair, B. et al. (2017) Lancet Neurol 16: 898–907.
Association of restless legs syndrome 
with risk of suicide and self‑harm
Given the association between RLS and multiple chronic 
physical and mental conditions, it is unsurprising that RLS 
has been linked with an increase of 30–90% in all-cause 
mortality. However, teasing apart whether RLS itself pre-
disposes patients to increased mortality rates, and how that 
risk is mediated, is difficult due to the many confounders. 
This paper tried to assess the increased risk of self-harm or 
suicide that could be directly attributed to RLS. It used a 
large database pertaining to commercially insured individu-
als in the USA to retrospectively identify a study population 
with RLS: those aged 20–65 with at least one claim for RLS 
between 2006 and 2008. Individuals with previous history 
of self-harm, suicide, cardiovascular disease, or cancer were 
excluded. The 24,179 people with a history of RLS within 
this timeframe were then individually matched with six 
controls, and the incidence of self-harm or suicide in this 
case–control population was then calculated for the subse-
quent years 2009–2014. As expected, individuals with RLS 
had significantly more medical comorbidities such as diabe-
tes, obstructive sleep apnoea, and depression, and took more 
regular medications. They also tended to live more rurally. 
There were 119 recorded cases of suicide or self-harm in the 
total study population of 169,373 individuals followed over 
5 years. There was a significantly increased risk of suicide 
or self-harm in the RLS group after accounting for age, sex, 
and multiple potential confounders such as comorbidities, 
medications, alcohol use, and region of residence [hazard 
ratio 2.66 (1.70–4.15; 95% confidence interval)]. Further 
sensitivity analyses showed that the increased risk of sui-
cide or self-harm in the RLS group was maintained even 
if individuals with depression, obstructive sleep apnoea, or 
common chronic diseases were removed from the analysis.
Comment. This study demonstrated a robust association 
between RLS and self-harm or suicide in this particular 
data set. It analysed a very large population and used many 
covariates to try to control for confounders. It is unclear why 
RLS might be linked to self-harm or suicide, particularly as 
the study controlled for potential mediating factors such as 
depression and insomnia. The results should also be inter-
preted with caution as the data were based on a very small 
number of cases of self-harm or suicide in a retrospective, 
convenience data set comprising only insured individu-
als aged 20–65. In addition, despite efforts to control for 
covariates, there were still many potential confounders: for 
example, none of smoking status, alcohol consumption, or 
severity of depression was recorded in the data.
Zhuang, S. et  al. (2019) JAMA Network Open 
2(8):e1999966
Risk of resistant hypertension associated 
with restless legs syndrome and periodic 
limb movements during sleep: a study 
on 673 treated hypertensive individuals
Hypertension has been associated with a range of sleep 
disorders such as obstructive sleep apnoea and insomnia 
with short-sleep duration. RLS is associated with peri-
odic limb movements during sleep (PLMS) in over 80% of 
cases and this contributes to sleep fragmentation and dep-
rivation, which can drive hypertension. This retrospective 
study attempted to show a direct association between RLS 
and resistant hypertension, defined as hypertension that is 
uncontrolled despite three antihypertensives from different 
classes or controlled with four agents. The starting popula-
tion was 3511 adults who had undergone sleep assessments 
in clinic between 2002 and 2014. Of these, 673 had treated 
hypertension, and 272 of these met the criteria for resistant 
hypertension. Overall, 35.1% of this population had docu-
mented RLS. Individuals with resistant hypertension had 
significantly decreased sleep latency and lower mean oxygen 
saturations on polysomnography. Frequent RLS and PLMS 
(> 26 per hour) was also significantly associated with resist-
ant hypertension [odds ratio 1.99 (1.25–3.18; 95% confi-
dence interval)], and this association survived correction for 
confounders such as age, sex, comorbidities, insomnia, and 
BMI. Interestingly, those with less frequent RLS and PLMS 
did not have an increased risk of resistant hypertension in 
the multivariate analysis.
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Comment. RLS is much more prevalent in hyperten-
sive individuals than in the general population. This study 
showed a significant, potentially dose-dependent, associa-
tion of RLS and PLMS with resistant hypertension, sug-
gesting that the impact of RLS and PLMS on sleep might 
drive hypertension. This hypothesis would fit with other 
sleep disorders, such as obstructive sleep apnoea, being 
risk factors for hypertension, although the pathophysiology 
remains poorly understood. However, this was a small, ret-
rospective study of hypertensive individuals who agreed to 
a sleep study. There were many potential confounders, and 
cause-and-effect could not be demonstrated.
Hein, M. et al. (2019) Sleep Medicine 63: 46–56
Conclusion
The novel associations of RLS with self-harm and sui-
cide and resistant hypertension discussed here reinforce 
the importance of prompt and effective treatment of RLS. 
Knowledge of genetic risk factors should improve our under-
standing of the underlying pathology and might enable Men-
delian randomisation approaches to help disentangle the web 
of chronic disease associations with RLS.
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